{"markup":"\u003C?xml version=\u00221.0\u0022 encoding=\u0022UTF-8\u0022 ?\u003E\n    \u003Chtml version=\u0022HTML+RDFa+MathML 1.1\u0022\n    xmlns:content=\u0022http:\/\/purl.org\/rss\/1.0\/modules\/content\/\u0022\n    xmlns:dc=\u0022http:\/\/purl.org\/dc\/terms\/\u0022\n    xmlns:foaf=\u0022http:\/\/xmlns.com\/foaf\/0.1\/\u0022\n    xmlns:og=\u0022http:\/\/ogp.me\/ns#\u0022\n    xmlns:rdfs=\u0022http:\/\/www.w3.org\/2000\/01\/rdf-schema#\u0022\n    xmlns:sioc=\u0022http:\/\/rdfs.org\/sioc\/ns#\u0022\n    xmlns:sioct=\u0022http:\/\/rdfs.org\/sioc\/types#\u0022\n    xmlns:skos=\u0022http:\/\/www.w3.org\/2004\/02\/skos\/core#\u0022\n    xmlns:xsd=\u0022http:\/\/www.w3.org\/2001\/XMLSchema#\u0022\n    xmlns:mml=\u0022http:\/\/www.w3.org\/1998\/Math\/MathML\u0022\u003E\n  \u003Chead\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_YjAJQgxDlFX6S-O02jj9jCrVbrwlY3CGgCg1FzPlvBs.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nif(typeof window.MathJax === \u0022undefined\u0022) window.MathJax = { menuSettings: { zoom: \u0022Click\u0022 } };\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_waP91NpgGpectm_6Y2XDEauLJ8WCSCBKmmA87unpp2E.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.googletagmanager.com\/gtag\/js?id=G-0K57TCX5BY\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nwindow.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag(\u0022js\u0022, new Date());gtag(\u0022set\u0022, \u0022developer_id.dMDhkMT\u0022, true);gtag(\u0022config\u0022, \u0022G-0K57TCX5BY\u0022, {\u0022groups\u0022:\u0022default\u0022,\u0022anonymize_ip\u0022:true});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\njQuery.extend(Drupal.settings, {\u0022basePath\u0022:\u0022\\\/\u0022,\u0022pathPrefix\u0022:\u0022\u0022,\u0022highwire\u0022:{\u0022ac\u0022:{\u0022medrxiv;2021.02.28.21252645v1\u0022:{\u0022access\u0022:{\u0022full\u0022:true},\u0022pisa_id\u0022:\u0022medrxiv;2021.02.28.21252645v1\u0022,\u0022apath\u0022:\u0022\u0022,\u0022jcode\u0022:\u0022medrxiv\u0022}},\u0022processed\u0022:[\u0022highwire_math\u0022],\u0022markup\u0022:[{\u0022requested\u0022:\u0022full-text\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022medrxiv;2021.02.28.21252645v1\u0022}]},\u0022instances\u0022:\u0022{\\u0022highwire_abstract_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:20,\\u0022height\\u0022:20,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-abstract-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022right center\\u0022,\\u0022my\\u0022:\\u0022left center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022shift\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter click \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_author_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-author-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022top center\\u0022,\\u0022my\\u0022:\\u0022bottom center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_reflinks_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022mimic\\u0022:\\u0022top center\\u0022,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-ref-link-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022bottom left\\u0022,\\u0022my\\u0022:\\u0022top left\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022flip\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}}}\u0022,\u0022qtipDebug\u0022:\u0022{\\u0022leaveElement\\u0022:0}\u0022,\u0022googleanalytics\u0022:{\u0022account\u0022:[\u0022G-0K57TCX5BY\u0022],\u0022trackOutbound\u0022:1,\u0022trackMailto\u0022:1,\u0022trackDownload\u0022:1,\u0022trackDownloadExtensions\u0022:\u00227z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip\u0022,\u0022trackColorbox\u0022:1},\u0022ajaxPageState\u0022:{\u0022js\u0022:{\u0022\\\/\\\/cdn.jsdelivr.net\\\/qtip2\\\/2.2.1\\\/jquery.qtip.min.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_article_reference_popup.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_at_symbol.js\u0022:1,\u00220\u0022:1,\u0022sites\\\/all\\\/modules\\\/contrib\\\/google_analytics\\\/googleanalytics.js\u0022:1,\u0022https:\\\/\\\/www.googletagmanager.com\\\/gtag\\\/js?id=G-0K57TCX5BY\u0022:1,\u00221\u0022:1}}});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__dn-cpI1YtkU_iLHgA5WhlkxgYWyat_IxjF_B-WSYrpE__a9hIbt0eaZ7d5nhwnm2weG8R_2eXK4EvoOx9dOxouHE__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__HGACIFBlu2o05y3afvqlt5wrE_5Dn6MXsexfuEpeIwg__t4SOPxucAPoV3Os7g8dXqyMB1HRXQridRJ82X7nE33E__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink rel=\u0027stylesheet\u0027 type=\u0027text\/css\u0027 href=\u0027\/sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css\u0027 \/\u003E\u003C\/head\u003E\u003Cbody\u003E\u003Cdiv class=\u0022panels-ajax-tab-panel panels-ajax-tab-panel-article-tab-full-text\u0022\u003E\u003Cdiv class=\u0022panel-display panel-1col clearfix\u0022 \u003E\n  \u003Cdiv class=\u0022panel-panel panel-col\u0022\u003E\n    \u003Cdiv\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup\u0022 \u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 data-highwire-cite-ref-tooltip-instance=\u0022highwire_reflinks_tooltip\u0022 class=\u0022content-block-markup\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cdiv class=\u0022article fulltext-view \u0022\u003E\u003Cspan class=\u0022highwire-journal-article-marker-start\u0022\u003E\u003C\/span\u003E\u003Cdiv class=\u0022section abstract\u0022 id=\u0022abstract-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAbstract\u003C\/h2\u003E\u003Cp id=\u0022p-2\u0022\u003EThe coronavirus disease 2019 (COVID-19) is heterogeneous and our understanding of the biological mechanisms of host response to the novel viral infection remains limited. Identification of meaningful clinical subphenotypes may benefit pathophysiological study, clinical practice, and clinical trials. Here, our aim was to derive and validate COVID-19 subphenotypes using machine learning and routinely collected clinical data, assess temporal patterns of these subphenotypes during the pandemic course, and examine their interaction with social determinants of health (SDoH). We retrospectively analyzed 14418 COVID-19 patients in five major medical centers in New York City (NYC), between March 1 and June 12, 2020. Using clustering analysis, four biologically distinct subphenotypes were derived in the development cohort (N = 8199). Importantly, the identified subphenotypes were highly predictive of clinical outcomes (especially 60-day mortality). Sensitivity analyses in the development cohort, and re-derivation and prediction in the internal (N = 3519) and external (N = 3519) validation cohorts confirmed the reproducibility and usability of the subphenotypes. Further analyses showed varying subphenotype prevalence across the peak of the outbreak in NYC. We also found that SDoH specifically influenced mortality outcome in Subphenotype IV, which is associated with older age, worse clinical manifestation, and high comorbidity burden. Our findings may lead to a better understanding of how COVID-19 causes disease in different populations and potentially benefit clinical trial development. The temporal patterns and SDoH implications of the subphenotypes may add new insights to health policy to reduce social disparity in the pandemic.\u003C\/p\u003E\u003C\/div\u003E\u003Cp id=\u0022p-15\u0022\u003EThe outbreak of coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has led to a pandemic that imposed tremendous pressure on healthcare systems globally\u003Csup\u003E\u003Ca id=\u0022xref-ref-1-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-1\u0022\u003E1\u003C\/a\u003E\u003C\/sup\u003E. As the pandemic continues and the second wave has emerged in the US and many other countries, research is still needed to understand how SARS-CoV-2 causes the wide spectrum of COVID-19 disease. Previous studies have uncovered substantial variation in the host response to SARS-CoV-2 and the variable clinical manifestations of this disease, including respiratory failure, kidney injury, and cardiovascular dysfunction\u003Csup\u003E\u003Ca id=\u0022xref-ref-2-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-2\u0022\u003E2\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-8-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-8\u0022\u003E8\u003C\/a\u003E\u003C\/sup\u003E. Pivotal studies of corticosteroids\u003Csup\u003E\u003Ca id=\u0022xref-ref-9-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-9\u0022\u003E9\u003C\/a\u003E\u003C\/sup\u003E and anticoagulation\u003Csup\u003E\u003Ca id=\u0022xref-ref-10-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-10\u0022\u003E10\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-11-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-11\u0022\u003E11\u003C\/a\u003E\u003C\/sup\u003E demonstrate differential responses in distinct subpopulations based on severity of disease. The pathophysiology of differential organ dysfunction in COVID-19 remains unclear across varied patient populations. Prior to the COVID-19 pandemic, identification of biologically distinct, data driven subphenotypes\u003Csup\u003E\u003Ca id=\u0022xref-ref-12-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-12\u0022\u003E12\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-13-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-13\u0022\u003E13\u003C\/a\u003E\u003C\/sup\u003E has helped to disentangle complex syndromic disease such as sepsis\u003Csup\u003E\u003Ca id=\u0022xref-ref-14-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-15-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-15\u0022\u003E15\u003C\/a\u003E\u003C\/sup\u003E, ARDS\u003Csup\u003E\u003Ca id=\u0022xref-ref-16-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-16\u0022\u003E16\u003C\/a\u003E\u003C\/sup\u003E, heart failure\u003Csup\u003E\u003Ca id=\u0022xref-ref-17-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-17\u0022\u003E17\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-18-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-18\u0022\u003E18\u003C\/a\u003E\u003C\/sup\u003E, diabetes\u003Csup\u003E\u003Ca id=\u0022xref-ref-19-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-19\u0022\u003E19\u003C\/a\u003E\u003C\/sup\u003E, and Alzheimer\u2019s disease\u003Csup\u003E\u003Ca id=\u0022xref-ref-20-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-20\u0022\u003E20\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-16\u0022\u003EIdentifying robust subphenotypes in COVID-19 patients could lead to improved understanding of biological mechanisms of host response to SARS-CoV-2 infection and may identify subpopulations that could be prioritized for clinical trial enrollment\u003Csup\u003E\u003Ca id=\u0022xref-ref-13-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-13\u0022\u003E13\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-21-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-21\u0022\u003E21\u003C\/a\u003E\u003C\/sup\u003E. Previous efforts\u003Csup\u003E\u003Ca id=\u0022xref-ref-22-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-24-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-24\u0022\u003E24\u003C\/a\u003E\u003C\/sup\u003E have been made in this area but remain limited probably due to cohort size, data availability, and lacking evaluation of robustness and usability of the identified subphenotypes. In addition, the hospitalized case fatality rate of COVID-19 has varied over the course of the pandemic\u003Csup\u003E\u003Ca id=\u0022xref-ref-25-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-26-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-26\u0022\u003E26\u003C\/a\u003E\u003C\/sup\u003E and according to social determinants of health (SDoH)\u003Csup\u003E\u003Ca id=\u0022xref-ref-27-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-27\u0022\u003E27\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-29-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-29\u0022\u003E29\u003C\/a\u003E\u003C\/sup\u003E. Exploration of temporal patterns and SDoH characteristics in conjunction with subphenotypes may derive new insights to improve public health.\u003C\/p\u003E\u003Cp id=\u0022p-17\u0022\u003EIn this analysis, our goal was to derive and validate COVID-19 subphenotypes amongst a population of patients who presented to the emergency department (ED) or were hospitalized in multiple health systems in New York City (NYC). Specifically, we used routinely collected clinical data to first derive subphenotypes using the agglomerative hierarchical clustering model. Then, multiple strategies in data pre-processing, data filtering, and data-driven models (both unsupervised clustering model and supervised predictive model) were used to confirm reproducibility and usability of the identified subphenotypes. After that, statistical analyses were conducted to evaluate the characteristics and clinical outcomes of the subphenotypes. Further analyses were performed to examine temporal patterns of the subphenotypes and impacts of SDoH status on subphenotype-level outcomes. The overall workflow of our study is illustrated in \u003Ca id=\u0022xref-fig-1-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFigure 1\u003C\/a\u003E.\u003C\/p\u003E\u003Cdiv id=\u0022F1\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F1.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022A schematic of the analysis plan. a. Strategy for construction of development, internal validation, and external validation cohorts. b. Data preparation for clustering analysis. c. Derivation of subphenotypes in the development c. cohort. Reproducibility of the identified subphenotypes were evaluated in multiple ways, including (d) sensitivity analyses in the development cohort and subphenotype re-derivation in the internal validation cohort; and (e) Training subphenotype predictive model in the development cohort and (f) using it to predict subphenotype memberships of patients in the external validation cohort. (g) further analyses were conducted to interpret subphenotypes, explore temporal patterns of subphenotypes during the pandemic, and evaluate impact of SDoH characterisitics on subphenotypes. Abbreviations: MMC = Montefiore Medical Center; MSHS = Mount Sinai Health System; NYP-CUMC = New York Presbyterian - Columbia University Medical Center; NYP-WCMC = New York Presbyterian - Weill Cornell Medical Center; NYU-LMC = New York University Langone Medical Center; SDoH = social determinants of health; UMAP = Uniform Manifold Approximation and Projection\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-762107447\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;A schematic of the analysis plan.\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;a\u0026lt;\/strong\u0026gt;. Strategy for construction of development, internal validation, and external validation cohorts. \u0026lt;strong\u0026gt;b\u0026lt;\/strong\u0026gt;. Data preparation for clustering analysis. \u0026lt;strong\u0026gt;c\u0026lt;\/strong\u0026gt;. Derivation of subphenotypes in the development \u0026lt;strong\u0026gt;c\u0026lt;\/strong\u0026gt;. cohort. Reproducibility of the identified subphenotypes were evaluated in multiple ways, including \u0026lt;strong\u0026gt;(d)\u0026lt;\/strong\u0026gt; sensitivity analyses in the development cohort and subphenotype re-derivation in the internal validation cohort; and \u0026lt;strong\u0026gt;(e)\u0026lt;\/strong\u0026gt; Training subphenotype predictive model in the development cohort and \u0026lt;strong\u0026gt;(f)\u0026lt;\/strong\u0026gt; using it to predict subphenotype memberships of patients in the external validation cohort. \u0026lt;strong\u0026gt;(g)\u0026lt;\/strong\u0026gt; further analyses were conducted to interpret subphenotypes, explore temporal patterns of subphenotypes during the pandemic, and evaluate impact of SDoH characterisitics on subphenotypes. Abbreviations: MMC = Montefiore Medical Center; MSHS = Mount Sinai Health System; NYP-CUMC = New York Presbyterian - Columbia University Medical Center; NYP-WCMC = New York Presbyterian - Weill Cornell Medical Center; NYU-LMC = New York University Langone Medical Center; SDoH = social determinants of health; UMAP = Uniform Manifold Approximation and Projection\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 1.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F1.medium.gif\u0022 width=\u0022285\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 1.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F1.medium.gif\u0022 width=\u0022285\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F1.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 1.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F1.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 1.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EA schematic of the analysis plan.\u003C\/span\u003E\u003Cp id=\u0022p-18\u0022 class=\u0022first-child\u0022\u003E\u003Cstrong\u003Ea\u003C\/strong\u003E. Strategy for construction of development, internal validation, and external validation cohorts. \u003Cstrong\u003Eb\u003C\/strong\u003E. Data preparation for clustering analysis. \u003Cstrong\u003Ec\u003C\/strong\u003E. Derivation of subphenotypes in the development \u003Cstrong\u003Ec\u003C\/strong\u003E. cohort. Reproducibility of the identified subphenotypes were evaluated in multiple ways, including\u003C\/p\u003E\u003Cp id=\u0022p-19\u0022\u003E\u003Cstrong\u003E(d)\u003C\/strong\u003E sensitivity analyses in the development cohort and subphenotype re-derivation in the internal validation cohort; and \u003Cstrong\u003E(e)\u003C\/strong\u003E Training subphenotype predictive model in the development cohort and \u003Cstrong\u003E(f)\u003C\/strong\u003E using it to predict subphenotype memberships of patients in the external validation cohort. \u003Cstrong\u003E(g)\u003C\/strong\u003E further analyses were conducted to interpret subphenotypes, explore temporal patterns of subphenotypes during the pandemic, and evaluate impact of SDoH characterisitics on subphenotypes.\u003C\/p\u003E\u003Cp id=\u0022p-20\u0022\u003EAbbreviations: MMC = Montefiore Medical Center; MSHS = Mount Sinai Health System; NYP-CUMC = New York Presbyterian - Columbia University Medical Center; NYP-WCMC = New York Presbyterian - Weill Cornell Medical Center; NYU-LMC = New York University Langone Medical Center; SDoH = social determinants of health; UMAP = Uniform Manifold Approximation and Projection\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EResults\u003C\/h2\u003E\u003Cdiv id=\u0022sec-2\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EPatients\u003C\/h3\u003E\u003Cp id=\u0022p-21\u0022\u003EA total of 14418 patients with confirmed COVID-19 between March 1st and June 12\u003Csup\u003Eth\u003C\/sup\u003E 2020, treated in ED or inpatient settings, were included for analysis from the five major medical centers in New York City (NYC), including New York University Langone Medical Center (NYU-LMC), New York Presbyterian - Weill Cornell Medical Center (NYP-WCMC), Mount Sinai Health System (MSHS), Montefiore Medical Center (MMC), and New York Presbyterian - Columbia University Medical Center (NYP-CUMC). Details of inclusion and exclusion criteria are presented in eFigure 1 in Supplement. Considering population diversity (especially race) of the five medical centers (see eTable 1 in Supplement), we combined NYU-LMC, NYP-WCMC, MSHS, and MMC and randomly divided them into the development cohort (70%) and internal validation cohort (30%); patients of NYP-CUMC were used as the external validation cohort (see \u003Ca id=\u0022xref-fig-1-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFigure 1\u003C\/a\u003E and eFigure. 1 in Supplement).\u003C\/p\u003E\u003Cp id=\u0022p-22\u0022\u003EThe development cohort contained a total of 8199 patients with a median age of 65.35 (interquartile range [IQR] [50.57, 75.17]) years old, consisting of 3787 (46.2%) females, 2036 (24.8%) white patients, and 2155 (26.3%) black patients. The internal validation cohort contained a total of 3519 patients with similar patient characteristics when compared with the development cohort, with a median age of 63.51 (IQR [50.95, 75,17]) years old, consisting of 1585 (45.0%) females, 838 (23.8%) white patients, and 915 (26%) black patients. The external validation cohort contained a total of 2700 patients. It had a median age of 65.85 (IQR [51.08, 77.38]) years old and consisted of 1305 (48.3%) females, 675 (25.0%) white patients, and 545 (20.2%) black patients. Across the three cohorts, the overall 60-day mortality rates after ED or hospital discharge were 18.65%, 19.78%, and 20.59%, respectively. More details of the characteristics of the studied cohorts appeared in \u003Ca id=\u0022xref-table-wrap-1-1\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable 1\u003C\/a\u003E.\u003C\/p\u003E\u003Cdiv id=\u0022T1\u0022 class=\u0022table pos-float\u0022\u003E\u003Cdiv class=\u0022table-inline table-callout-links\u0022\u003E\u003Cdiv class=\u0022callout\u0022\u003E\u003Cspan\u003EView this table:\u003C\/span\u003E\u003Cul class=\u0022callout-links\u0022\u003E\u003Cli class=\u0022view-inline first\u0022\u003E\u003Ca href=\u0022\u0022 class=\u0022table-expand-inline\u0022 data-table-url=\u0022\/highwire\/markup\/311430\/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0026amp;table-expand-inline=1\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView inline\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022view-popup\u0022\u003E\u003Ca href=\u0022\/highwire\/markup\/311430\/expansion?width=1000\u0026amp;height=500\u0026amp;iframe=true\u0026amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0022 class=\u0022colorbox colorbox-load table-expand-popup\u0022 rel=\u0022gallery-fragment-tables\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView popup\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022download-ppt last\u0022\u003E\u003Ca href=\u0022\/highwire\/powerpoint\/311430\u0022 class=\u0022highwire-figure-link highwire-figure-link-ppt\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload powerpoint\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022table-caption\u0022\u003E\u003Cspan class=\u0022table-label\u0022\u003ETable 1.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003ECharacteristics of the development, internal validation, and external validation cohorts\u003C\/span\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-3\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ESubphenotypes derivation\u003C\/h3\u003E\u003Cp id=\u0022p-23\u0022\u003EIn the development cohort, the agglomerative hierarchical clustering model identified 4 distinct subphenotypes based on presenting clinical data of the patients (see eResults, eFigures 3 and 4 in Supplement). Characteristics including demographics, clinical variables, comorbidities, clinical outcomes, and medication treatments across the 4 subphenotypes were presented in \u003Ca id=\u0022xref-table-wrap-2-1\u0022 class=\u0022xref-table\u0022 href=\u0022#T2\u0022\u003ETable 2\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-2-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFigures 2\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-3-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003E3\u003C\/a\u003E.\u003C\/p\u003E\u003Cdiv id=\u0022T2\u0022 class=\u0022table pos-float\u0022\u003E\u003Cdiv class=\u0022table-inline table-callout-links\u0022\u003E\u003Cdiv class=\u0022callout\u0022\u003E\u003Cspan\u003EView this table:\u003C\/span\u003E\u003Cul class=\u0022callout-links\u0022\u003E\u003Cli class=\u0022view-inline first\u0022\u003E\u003Ca href=\u0022\u0022 class=\u0022table-expand-inline\u0022 data-table-url=\u0022\/highwire\/markup\/311431\/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0026amp;table-expand-inline=1\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView inline\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022view-popup last\u0022\u003E\u003Ca href=\u0022\/highwire\/markup\/311431\/expansion?width=1000\u0026amp;height=500\u0026amp;iframe=true\u0026amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0022 class=\u0022colorbox colorbox-load table-expand-popup\u0022 rel=\u0022gallery-fragment-tables\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView popup\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022table-caption\u0022\u003E\u003Cspan class=\u0022table-label\u0022\u003ETable 2.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003ECharacteristics of the identified subphenotypes (development cohort)\u003C\/span\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022F2\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F2.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Chord diagrams showing differences in abnormal clinical variables and comorbidity burden among subphenotypes. a. Abnormal biomarkers vs. all subphenotypes. b. Abnormal biomarkers vs. each subphenotype. c. Comorbidities vs. all subphenotypes. d. Comorbidities vs. each subphenotype Abbreviations: ATA = asthma; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; HF = heart failure; HLD = hyperlipidemia; HTN = hypertension.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-762107447\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Chord diagrams showing differences in abnormal clinical variables and comorbidity burden among subphenotypes.\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;a\u0026lt;\/strong\u0026gt;. Abnormal biomarkers vs. all subphenotypes. \u0026lt;strong\u0026gt;b\u0026lt;\/strong\u0026gt;. Abnormal biomarkers vs. each subphenotype. \u0026lt;strong\u0026gt;c\u0026lt;\/strong\u0026gt;. Comorbidities vs. all subphenotypes. \u0026lt;strong\u0026gt;d\u0026lt;\/strong\u0026gt;. Comorbidities vs. each subphenotype Abbreviations: ATA = asthma; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; HF = heart failure; HLD = hyperlipidemia; HTN = hypertension.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 2.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F2.medium.gif\u0022 width=\u0022303\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 2.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F2.medium.gif\u0022 width=\u0022303\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F2.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 2.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F2.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 2.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EChord diagrams showing differences in abnormal clinical variables and comorbidity burden among subphenotypes.\u003C\/span\u003E\u003Cp id=\u0022p-24\u0022 class=\u0022first-child\u0022\u003E\u003Cstrong\u003Ea\u003C\/strong\u003E. Abnormal biomarkers vs. all subphenotypes. \u003Cstrong\u003Eb\u003C\/strong\u003E. Abnormal biomarkers vs. each subphenotype. \u003Cstrong\u003Ec\u003C\/strong\u003E. Comorbidities vs. all subphenotypes. \u003Cstrong\u003Ed\u003C\/strong\u003E. Comorbidities vs. each subphenotype\u003C\/p\u003E\u003Cp id=\u0022p-25\u0022\u003EAbbreviations: ATA = asthma; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; HF = heart failure; HLD = hyperlipidemia; HTN = hypertension.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022F3\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F3.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Kaplan-Meier plots for 60-day mortality by subphenotypes. The survival probabilities were shown with 95% confidence interval.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-762107447\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;span xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot; class=\u0026quot;caption-title\u0026quot;\u0026gt;Kaplan-Meier plots for 60-day mortality by subphenotypes.\u0026lt;\/span\u0026gt; The survival probabilities were shown with 95% confidence interval.\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 3.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F3.medium.gif\u0022 width=\u0022440\u0022 height=\u0022364\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 3.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F3.medium.gif\u0022 width=\u0022440\u0022 height=\u0022364\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F3.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 3.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F3.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 3.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EKaplan-Meier plots for 60-day mortality by subphenotypes.\u003C\/span\u003E\u003Cp id=\u0022p-26\u0022 class=\u0022first-child\u0022\u003EThe survival probabilities were shown with 95% confidence interval.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-4\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003ESubphenotype I\u003C\/h4\u003E\u003Cp id=\u0022p-27\u0022\u003Econsisted of 2707 (33.02%) patients. Compared to the others, it included more younger (median age 57.45 years, IQR [42.70, 70.02]) and female (N = 1601 [59.15%]) patients.Those patients had more normal values across all clinical variables and lower chronic comorbidity burden. The patients also had better clinical outcomes including a low 60-day mortality (N = 188 [6.94%]) and a low rates of mechanical ventilation (N = 190 [7.02%]) and ICU admission (N = 242 [8.94%]).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-5\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003ESubphenotype II\u003C\/h4\u003E\u003Cp id=\u0022p-28\u0022\u003Econsisted of 3047 (37.16%) patients. Compared to other subphenotypes, it included more male patients (N = 1941 [63.70%]) and was likely to have more abnormal inflammatory markers (such as C-reactive protein, erythrocyte sedimentation rate, interleukin 6, lactate dehydrogenase, lymphocyte count, neutrophil count, white blood cell count, and ferritin) and markers of hepatic dysfunctions (such as ferritin, alanine aminotransferase, aspartate aminotransferase, and bilirubin). Overall comorbidity burden of Subphenotype II was low. Clinical outcomes including 60-day mortality (N = 528 [17.33%]), mechanical ventilation (N = 527 [17.30%]), and ICU admission (N = 675 [22.15%]) of Subphenotype II were at a moderate level.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-6\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003ESubphenotype III\u003C\/h4\u003E\u003Cp id=\u0022p-29\u0022\u003Eincluded 1486 (18.12%) patients, consisting of more older (median age 69.45 years, IQR [57.05, 79.62]) and black (N = 503 [33.85%]) patients, compared to subphenotypes I and II. Those patients of Subphenotype III were likely to have more abnormal renal dysfunction markers (such as blood urea nitrogen, creatinine, chloride, and sodium) and hematologic dysfunction markers (such as d-dimer, hemoglobin, and red blood cell distribution width). Overall comorbidity burden of Subphenotype III was high. Clinical outcomes including 60-day mortality (N = 337 [22.68%]), intubation (N = 195 [13.12%]), and ICU admission (N =242 [16.29%]) of Subphenotype II were close to that of Subphenotype II and at a moderate level as well.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-7\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003ESubphenotype IV\u003C\/h4\u003E\u003Cp id=\u0022p-30\u0022\u003Eincluded 959 (11.70%) patients. Compared to other subphenotypes, it included more older (median age 75.53 years, IQR [64.10, 84.83]) and male (N = 588 [61.31%]) patients. Those patients of Subphenotype IV had more abnormal values across all clinical variables and higher chronic comorbidity burden than the others. In line with its biological characteristics, Subphenotype IV had the worst clinical outcomes in 60-day mortality (N = 476 [49.64%]), intubation (N = 242 [25.23%]), and ICU admission (N =335 [34.93%]). In addition, the medications including antibiotics, corticosteroids, and vasopressor were more frequently used in Subphenotype IV.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-8\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ESubphenotype reproducibility and prediction\u003C\/h3\u003E\u003Cp id=\u0022p-31\u0022\u003EIn the development cohort, sensitivity analyses under two different settings (sensitivity to quality control and outliers and sensitivity to clustering methods) confirmed the underlying 4-cluster structure of the data (see eResults, eFigures 3 and 4, and eTable 5 in Supplement). Patients\u2019 memberships of the 4 clusters re-derived by sensitivity analyses were highly consistent with those derived in the primary analysis (see eFigure 6 in Supplement). Moreover, we did not find substantial changes in clinical characteristics of the subphenotypes in the sensitivity analyses (see eTables 6 and 7 in Supplement).\u003C\/p\u003E\u003Cp id=\u0022p-32\u0022\u003ESubphenotypes were also re-derived in the internal validation cohort, where the 4-cluster structure was found as the optimal fit as well (see eResults and eFigure7 in Supplement). Clinical characteristics of the re-derived subphenotypes in the internal validation cohort, including demographics, laboratory variables, comorbidities, and clinical outcomes, also showed very similar patterns with the subphenotypes derived in the primary analysis (see \u003Ca id=\u0022xref-fig-3-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFigure 3\u003C\/a\u003E, and eTable 8 and eFigure 8 in Supplement).\u003C\/p\u003E\u003Cp id=\u0022p-33\u0022\u003ETo further evaluate subphenotype robustness and usability, we trained a predictive model of subphenotypes in the development cohort and used it to predict subphenotype membership in the external validation cohort. Clinical variables of presenting laboratory tests for clustering analysis were used as candidate predictors. The trained predictive model (XGBoost classifier) achieved very high performance in predicting each subphenotype (see eFigure 9 in Supplement). SHapley Additive exPlanation (SHAP) values illustrated contributions of the clinical variables in distinguishing each subphenotype from others (see eFigure 10 in Supplement). Patterns of the produced SHAP values were highly in line with the subphenotype characteristics: 1) normal values of the clinical variables indicated Subphenotype I; 2) abnormal inflammatory and hepatic markers were predictive of Subphenotype II; 3) abnormal renal and hematologic markers indicated were likely to indicate Subphenotype III; 4) Subphenotype IV was associated with abnormal values of most variables. After that, the trained predictive model was used to predict subphenotype memberships of patients in the external validation cohort. The predicted subphenotypes in the external validation cohort were well separated in the UMAP space (see eFigure 11 in Supplement) and showed clinical characteristics similar to findings in the primary analysis (see \u003Ca id=\u0022xref-fig-3-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFigure 3\u003C\/a\u003E, and eTable 9 and eFigure 12 in Supplement).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-9\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ETemporal characteristics of subphenotypes\u003C\/h3\u003E\u003Cp id=\u0022p-34\u0022\u003ETemporal patterns of the COVID-19 subphenotypes were illustrated by the bar charts, showing the composition of subphenotype memberships of patients confirmed per week, since the outbreak in NYC, i.e., March 1, 2020 (see \u003Ca id=\u0022xref-fig-4-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFigures 4a-c\u003C\/a\u003E). Except week 1 and week 14 that had few patients confirmed, the composition of the four subphenotypes per week evolved over time and showed similar patterns across the development, internal validation, and external validation cohorts. In general, patients with confirmed SARS-CoV-2 infection rapidly increased within the first month since the outbreak and reached the peak at week 5 (early April). Subphenotype I (mild symptom) and Subphenotype II (moderate symptom, low comorbidity burden) dominated the time period prior to the peak (first 4 weeks since outbreak). In contrast, Subphenotype IV (severe symptom, high comorbidity burden) had a low proportion within the first 4 weeks but showed a largely increased proportion from week 6 to week 9. Since week 10, the proportion of Subphenotype I gradually increased while others especially Subphenotype IV shrank. Subphenotype III (moderate symptom, high comorbidity burden) had a relatively stable proportion over time.\u003C\/p\u003E\u003Cdiv id=\u0022F4\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F4.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Plots showing temporal patterns and SDoH implications of subphenotypes. a-c. Proportions of subphenotype memberships of patients confirmed per week, since March 1, 2020. d. Log odds (mean values and standard deviation) showing associations between individual SDoH characteristics and 60-day mortality risk, using logistic regression analysis, adjusting for age and sex. e. Plot showing alteration of 60-day mortality rate of each SDoH stratum to that of subphenotype level.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-762107447\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Plots showing temporal patterns and SDoH implications of subphenotypes.\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;a-c\u0026lt;\/strong\u0026gt;. Proportions of subphenotype memberships of patients confirmed per week, since March 1, 2020. \u0026lt;strong\u0026gt;d\u0026lt;\/strong\u0026gt;. Log odds (mean values and standard deviation) showing associations between individual SDoH characteristics and 60-day mortality risk, using logistic regression analysis, adjusting for age and sex. \u0026lt;strong\u0026gt;e\u0026lt;\/strong\u0026gt;. Plot showing alteration of 60-day mortality rate of each SDoH stratum to that of subphenotype level.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 4.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F4.medium.gif\u0022 width=\u0022302\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 4.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F4.medium.gif\u0022 width=\u0022302\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F4.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 4.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/03\/02\/2021.02.28.21252645\/F4.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 4.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EPlots showing temporal patterns and SDoH implications of subphenotypes.\u003C\/span\u003E\u003Cp id=\u0022p-35\u0022 class=\u0022first-child\u0022\u003E\u003Cstrong\u003Ea-c\u003C\/strong\u003E. Proportions of subphenotype memberships of patients confirmed per week, since March 1, 2020. \u003Cstrong\u003Ed\u003C\/strong\u003E. Log odds (mean values and standard deviation) showing associations between individual SDoH characteristics and 60-day mortality risk, using logistic regression analysis, adjusting for age and sex. \u003Cstrong\u003Ee\u003C\/strong\u003E. Plot showing alteration of 60-day mortality rate of each SDoH stratum to that of subphenotype level.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-10\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EImpact of SDoH on subphenotypes\u003C\/h3\u003E\u003Cp id=\u0022p-36\u0022\u003EIn general, worse SDoH in terms the socioeconomic variables were likely related to Subphenotype IV (see eTable 10 in Supplement). Moreover, logistic regression analysis identified similar patterns of relationships between the SDoH variables with 60-day mortality risk across subphenotypes; however, absolute log odds of the SDoH variables varied across subphenotypes (see \u003Ca id=\u0022xref-fig-4-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFigure 4d\u003C\/a\u003E and eTable 11 in Supplement). For example, low absolute log odds were observed in all six SDoH variables in Subphenotype I. In contrast, we did see increased absolute log odds of all six SDoH variables in Subphenotype IV.\u003C\/p\u003E\u003Cp id=\u0022p-37\u0022\u003EAgglomerative hierarchical clustering based on the SDoH variables grouped the patients into a 3-cluster model (see eResults and eFigure 13 in Supplement), which can be interpreted as high (H), middle (M), and low (L) SDoH strata (see eTable 12 in Supplement). Stratum L, representing disadvantaged SDoH status, accounted for a slightly higher mortality rate (H vs. M vs. L, 17.59% vs. 19.91% vs.19.98%, P-value = 0.08). In addition, stratum L had a lower ICU admission rate (16.16%, P-value \u0026lt; 0.001). The relative high mortality but low ICU admission rate may be caused by critical care strain during periods of increased COVID-19 ICU demand, as suggested by a recent study\u003Csup\u003E\u003Ca id=\u0022xref-ref-30-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-30\u0022\u003E30\u003C\/a\u003E\u003C\/sup\u003E. Distributions of the SDoH strata by biological subphenotypes were shown in eTable 13 in Supplement. In the analysis to further explore how SDoH strata affected the outcome of each biological subphenotype, we found varied patterns of correlations between SDoH strata and 60-day mortality (see \u003Ca id=\u0022xref-fig-4-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFigure 4e\u003C\/a\u003E) by subphenotypes. Notably, in line with the results of the univariate analysis above, SDoH strata were likely to have a strong impact on the 60-day mortality in Subphenotype IV. Particularly, in Subphenotype IV, SDoH stratum L was associated with a 55.19% 60-mortality rate, which was 5.55% higher than the subphenotype level (49.64%, see \u003Ca id=\u0022xref-table-wrap-2-2\u0022 class=\u0022xref-table\u0022 href=\u0022#T2\u0022\u003ETable 2\u003C\/a\u003E) and 8.52% higher than that of the SDoH stratum H. In subphenotypes I, II, and III, we didn\u2019t find mortality rate discrepancy higher than 3% between any pair of SDoH strata. Similarly, considering stratum H as reference, stratum L had largely increased log odds of mortality in Subphenotype IV (log odds = 0.40, SD = 0.19, P-value = 0.04). (see eTable 13 in Supplement)\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-11\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EDiscussions\u003C\/h2\u003E\u003Cp id=\u0022p-38\u0022\u003EWe derived subphenotypes of COVID-19 patients treated at five major medical centers in NYC across the whole course of the first wave of the pandemic, using the clinical data at the presentation to the emergency department (ED) or hospital. Different from the previous subphenotype studies of COVID-19\u003Csup\u003E\u003Ca id=\u0022xref-ref-22-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-24-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-24\u0022\u003E24\u003C\/a\u003E\u003C\/sup\u003E, we focused on a larger, more representative, and diverse population presented at the ED and\/or hospitalized without COVID-19 specific therapy. We derived subphenotypes using clustering analysis in the development cohort and validated them using a combination of multiple validation strategies, including the use of different data processing, different data filtering, and different machine learning models (both unsupervised clustering and supervised predictive models). All validation approaches confirmed the reproducibility of the 4-cluster structure of the data and clinical characteristics of the identified subphenotypes. We would also highlight that all machine learning models used for subphenotype derivation and validation were performed only on the presenting clinical variables that were routinely collected in daily patient care and are available to providers by ED or hospital admission. This allows us to potentially capture the underlying variable mechanisms of the complex disease, but also enhances the generalizability and feasibility of the identified subphenotypes to be used in clinical practices and patient enrollment in clinical trials.\u003C\/p\u003E\u003Cp id=\u0022p-39\u0022\u003EImportantly, the 4 subphenotypes identified were significantly separated in demographics, clinical variables, and chronic comorbidities, and strongly predictive of the 60-day mortality outcome. Subphenotype IV included more older, male patients, abnormal markers indicating hyperinflammation, liver injury, cardiovascular problems, renal dysfunctions, and coagulation disorders, and a higher comorbidity burden compared to the other subphenotypes. In contrast, Subphenotype I was composed of relatively healthy, younger females who had more normal values across all markers and comorbidity burdens compared to the other subphenotypes. There was a strong concordance between their clinical profiles and outcomes, such as Subphenotype IV showed the worst clinical outcome while Subphenotype I showed the best outcome among the 4 subphenotypes. These are in line with observations reported in a previous small cohort study\u003Csup\u003E\u003Ca id=\u0022xref-ref-23-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-23\u0022\u003E23\u003C\/a\u003E\u003C\/sup\u003E. Interestingly, Subphenotypes II and III showed similar, moderate-level 60-day mortality rates, but their clinical characteristic profiles suggested that they were likely to have distinct biological mechanisms. In particular, results from our primary analysis and validation approaches demonstrated that Subphenotype II was correlated with relative hyperinflammation, while Subphenotype III was associated with renal injury, lower platelet level and a high comorbidity burden (significantly higher than Subphenotypes I and II, and equivalent to Subphenotype IV). Moreover, in accordance with the clinical characteristics and outcomes, the worse subphenotypes (Subphenotypes III and IV) were more likely to receive medications in antibiotics, corticosteroids, and vasopressor than the others. These findings suggested that our identified subphenotypes offer insight into the varied mechanisms of COVID-19.\u003C\/p\u003E\u003Cp id=\u0022p-40\u0022\u003ETypically, data-driven approaches for the identification of subphenotypes of human disease are based on the unsupervised clustering methods\u003Csup\u003E\u003Ca id=\u0022xref-ref-12-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-12\u0022\u003E12\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-14-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-16-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-16\u0022\u003E16\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-22-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E-\u003Ca id=\u0022xref-ref-24-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-24\u0022\u003E24\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-31-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-31\u0022\u003E31\u003C\/a\u003E\u003C\/sup\u003E. The natural attributes of the unsupervised methodology in discovering underlying patterns from data make them the best fit for subphenotype identification. Once the subphenotypes were determined, there would be a need of subphenotype membership assignments for new patients. However, previous studies barely discussed such down-stream usability of the identified subphenotypes. In this analysis, we built a supervised predictive model of the identified subphenotypes. Our predictive model achieved an ideal prediction performance in the development cohort and predicted subphenotypes in the external validation cohort that presented the same pattern of clinical characteristics with that of the originally derived subphenotypes. In this way, instead of validating the subphenotypes in a different route, the predictive model brought additional implications as: 1) it provides a feasible and accurate way to apply the identified subphenotypes to clinical practice; and 2) contributions of the clinical variables in subphenotype prediction calculated by the novel SHAP method showed concordant patterns with the subphenotypes\u2019 clinical characteristics and hence confirmed biological profiles of the subphenotypes in the multivariate prospective.\u003C\/p\u003E\u003Cp id=\u0022p-41\u0022\u003ETime is a crucial factor in the spread of COVID-19. Previous studies have examined the temporal trends of COVID-19 outcomes such as in-hospital mortality rate during the course of the pandemic\u003Csup\u003E\u003Ca id=\u0022xref-ref-25-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-26-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-26\u0022\u003E26\u003C\/a\u003E\u003C\/sup\u003E, but limited attention has been drawn on evolving patterns of COVID-19 phenotypes. We filled this gap in the present study. Our observations suggested varied temporal trends of the identified subphenotypes during the first 14 weeks of the pandemic in NYC. Interestingly, since the COVID-19 outbreak in NYC on March 1, 2020, Subphenotypes I and II dominated the time period prior to the peak (first 4 weeks since outbreak), possibly as they contained more relatively younger patients who may have had more frequent social activities to be infected. Subphenotype IV, with older age, worse health conditions, and poorer outcomes, was boosted within the second month (April 2020) post spread peak, consistent with tremendous mortality rate of NYC in April\u003Csup\u003E\u003Ca id=\u0022xref-ref-32-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-32\u0022\u003E32\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-42\u0022\u003EThis would suggest that younger, biologically strong patients (Subphenotypes I and II) got infections early and boosted the spread, while older, biologically vulnerable patients (Subphenotype IV) accounted for the second infections within a population probably due to housing. After that, the proportion of Subphenotype I out of all patients confirmed per week gradually expanded while that of the others, especially Subphenotype IV shrank. The potential reason would be that valuable experience (such as the improved use of masks and social distancing), reinforced health care systems, and announced health policies did protect the population who likely develop severe subphenotypes (Subphenotype IV). In general, such temporal trends of the novel biological subphenotypes would be a considerable, fine-grained explanation of the observed outcome (mortality rate) evolving trends in epidemiology\u003Csup\u003E\u003Ca id=\u0022xref-ref-25-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-43\u0022\u003ESDoH such as vulnerable socioeconomic neighborhood status have been associated with poor outcomes of COVID-19\u003Csup\u003E\u003Ca id=\u0022xref-ref-25-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-29-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-29\u0022\u003E29\u003C\/a\u003E\u003C\/sup\u003E. In this work, we explored the impact of SDoH on different biological subphenotypes from both univariate and multivariate perspectives. We first examined the associations of individual socioeconomic characteristics with mortality risk in each subphenotype. We then derived comprehensive SDoH strata using the data-driven clustering method and evaluated their correlations with mortality risk in each subphenotype. The results confirmed our hypothesis that SDoH impacts biological subphenotypes differently. The highly expanded mortality risk log odds of individual SDoH variables and discrepancy of mortality rate among SDoH strata indicate that SDoH has a much stronger association with mortality outcomes in Subphenotype IV, compared to the others. In other words, once a sick, elderly patient shows up with COVID-19 (Subphenotype IV), the disadvantaged socioeconomic status significantly increased their mortality. In contrast, disadvantaged SDoH status was unlikely to lead to significantly increased mortality risk in Subphenotype I. This evidence further demonstrated that the COVID-19 pandemic has disproportionately affected patients with lower socioeconomic status. In general, our findings added new information on social disparities in the COVID-19 pandemic. Unlike previous studies\u003Csup\u003E\u003Ca id=\u0022xref-ref-28-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-28\u0022\u003E28\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-29-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-29\u0022\u003E29\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-33-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-33\u0022\u003E33\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-34-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-34\u0022\u003E34\u003C\/a\u003E\u003C\/sup\u003E that focused on the entire population, we extended the study from a new angle by focusing on the biologically different populations (i.e., subphenotypes). Our findings also showed evidence that the identified subphenotypes would provide considerable guidance in health policy to reduce social disparities in the pandemic.\u003C\/p\u003E\u003Cdiv id=\u0022sec-12\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ELimitations\u003C\/h3\u003E\u003Cp id=\u0022p-44\u0022\u003EWhile this study presents a new contribution in the efforts to parse the biological heterogeneity of COVID-19, there remain several limitations. First of all, our data-driven approach relied on the availability of patient data. In this study, we identified subphenotypes using the routinely collected clinical variables that were correlated with COVID-19\u003Csup\u003E\u003Ca id=\u0022xref-ref-35-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-35\u0022\u003E35\u003C\/a\u003E\u003C\/sup\u003E and available in the INSIGHT database\u003Csup\u003E\u003Ca id=\u0022xref-ref-36-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-36\u0022\u003E36\u003C\/a\u003E\u003C\/sup\u003E. We were not able to extract presenting symptoms and vital data while the incorporation of such data would add in new insights.\u003C\/p\u003E\u003Cp id=\u0022p-45\u0022\u003ESecond, in our study, the analyzed data were collected at ED or hospital presentation, so the time between COVID-19 symptom onset to ED or hospital presentation could be a covariate of disease severity and clinical outcomes. However, such data was not available in the INSIGHT database.\u003C\/p\u003E\u003Cp id=\u0022p-46\u0022\u003EThird, missing values may affect the robustness of the identified subphenotypes. In order to address this issue, we excluded variables with high missingness. For the remaining variables, we used the state-of-the-art K-nearest neighbors imputation algorithm\u003Csup\u003E\u003Ca id=\u0022xref-ref-37-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-37\u0022\u003E37\u003C\/a\u003E\u003C\/sup\u003E. Even so, we still missed these real values hence may incorporate bias.\u003C\/p\u003E\u003Cp id=\u0022p-47\u0022\u003EFourth, our study was based on presenting clinical data, such that each patient was characterized in a snapshot. The full use of longitudinal data of patients may allow us to capture the complexity of the disease arc to identify interesting subphenotypes. Previous studies tried to derive COVID-19 subphenotypes based on longitudinal information\u003Csup\u003E\u003Ca id=\u0022xref-ref-22-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-24-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-24\u0022\u003E24\u003C\/a\u003E\u003C\/sup\u003E, yet they were based on univariate trajectory data in small cohorts. The collection of multivariate, longitudinal data in large cohorts remains challenging and modeling such data to identify subphenotypes requires improved data-driven methods\u003Csup\u003E\u003Ca id=\u0022xref-ref-12-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-12\u0022\u003E12\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-13-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-13\u0022\u003E13\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-21-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-21\u0022\u003E21\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-48\u0022\u003EFifth, this is a multiple institutional analysis in NYC. To evaluate the generalizability of the identified subphenotypes, further validation on data collected from other areas is needed in future work.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section data-availability\u0022 id=\u0022sec-14\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EData Availability\u003C\/h2\u003E\u003Cp id=\u0022p-49\u0022\u003EAll data studied in this work can be downloaded from INSIGHT clinical research network at https:\/\/insightcrn.org\/our-data\/, via request. Implementation of our work is based on Python 3.7 and R 3.6. More specifically, clustering models were implemented based on Python packages scikit-learn 0.23.2 (https:\/\/scikit-learn.org\/stable\/) and scipy 1.5.3 (https:\/\/www.scipy.org). Supervised predictive modeling was based on XGBoost 1.2.1 (https:\/\/xgboost.readthedocs.io\/en\/latest\/) and SHAP 0.35.0 (https:\/\/shap.readthedocs.io\/en\/latest\/). Data dimension reduction and visualization were performed based on Python package UMAP-learn 0.3.9 (https:\/\/umap-learn.readthedocs.io\/en\/latest\/). R package NbClust (https:\/\/cran.r-project.org\/web\/packages\/NbClust\/NbClust.pdf) was used to calculate measures of clusters to determine the optimal cluster number in agglomerative hierarchical clustering. Chord diagrams were created using R package circlize (https:\/\/cran.r-project.org\/web\/packages\/circlize\/index.html). All statistical tests and survival analyses were performed based on R.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-15\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EOnline Methods\u003C\/h2\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-16\u0022\u003E\u003Ch3\u003EStudy design and cohort description\u003C\/h3\u003E\u003Cp id=\u0022p-50\u0022\u003EWe used data of COVID-19 patients from INSIGHT Clinical Research Network (CRN)\u003Csup\u003E\u003Ca id=\u0022xref-ref-36-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-36\u0022\u003E36\u003C\/a\u003E\u003C\/sup\u003E. INSIGHT is funded by the Patient-Centered Outcomes Research Institute (PCORI) and aggregates clinical data of diverse patient populations across five academic medical centers in New York City (NYC), including New York University Langone Medical Center (NYU-LMC), New York Presbyterian - Weill Cornell Medical Center (NYP-WCMC), New York Presbyterian - Columbia University Medical Center (NYP-CUMC), Mount Sinai Health System (MSHS), and Montefiore Medical Center (MMC). COVID-19 diagnosis was defined as having at least one positive laboratory test result for SARS-CoV-2 infection or at least one ICD-10 diagnosis code for COVID-19 (see eMethods in Supplement). Study participants were adult patients who were diagnosed with COVID-19 and treated in ED or inpatient settings in these five health centers from March 1 to June 12, 2020. Criteria used to assess patient eligibility are illustrated in e\u003Ca id=\u0022xref-fig-1-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFigure 1\u003C\/a\u003E in Supplement. Exclusion criteria include younger than 18 years old; duplicated patient IDs; having no emergency department (ED) or inpatient (IP) admission within 14 days after COVID-19 confirmation; or having missing values on all clinical variables. Considering the population diversity of the five medical centers (see e\u003Ca id=\u0022xref-table-wrap-1-2\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable 1\u003C\/a\u003E in Supplement), we combined patients of NYU, NYP-WCMC, MSHS, and MMC and randomly divided them into the development cohort (70%) and internal validation cohort (30%). Patients of NYP-CUMC were used as the external validation cohort.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-17\u0022\u003E\u003Ch3\u003ECandidate variables for subphenotype identification\u003C\/h3\u003E\u003Cp id=\u0022p-51\u0022\u003EWe considered 30 clinical variables associated with COVID-19 onset, symptoms, or outcomes\u003Csup\u003E\u003Ca id=\u0022xref-ref-37-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-37\u0022\u003E37\u003C\/a\u003E\u003C\/sup\u003E and available in the INSIGHT database as the candidate variables to derive subphenotypes. The variables included inflammatory markers (C-reactive protein, erythrocyte sedimentation rate [ESR], interleukin 6 [IL-6], procalcitonin, bands [i.e., premature neutrophil], lactate dehydrogenase [LDH], lymphocyte count, neutrophil count, and white blood cell count), inflammatory and hepatic markers (albumin and ferritin), hepatic markers (alanine aminotransferase [ALT], aspartate aminotransferase [AST], and bilirubin), markers of cardiovascular conditions (creatine kinase [CK], lactate, troponin I, and troponin T), markers of renal dysfunctions (bicarbonate, blood urea nitrogen [BUN], creatinine, chloride, and sodium), markers of hematologic dysfunctions (d-dimer, hemoglobin, platelet count, prothrombin time [PT], red blood cell distribution width [RDW], and glucose), and oxygen saturation. For each patient, we extracted the first value of each clinical variable within the collection window, which was defined as: 1) time period from COVID-19 confirmation to the first inpatient encounter, if the patient has an inpatient admission within 14 days after confirmation; or 2) 14 days after COVID-19 confirmation if there was only ED encounters but no inpatient admissions following the COVID-19 diagnosis. If there was no record in the collection window, we extracted the last value within 3 days before confirmation (see e\u003Ca id=\u0022xref-fig-2-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFigure 2\u003C\/a\u003E in Supplement).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-18\u0022\u003E\u003Ch3\u003EOther clinical characteristics, clinical outcomes, and medications\u003C\/h3\u003E\u003Cp id=\u0022p-52\u0022\u003EWe also examined other clinical characteristics of the patients, including demographics, comorbidities, and body mass index (BMI). Demographics included age, sex, and race. Baseline comorbidities included hypertension, diabetes, coronary artery disease (CAD), heart failure, chronic obstructive pulmonary disease (COPD), asthma, cancer, obesity, and hyperlipidemia. For each patient, the most recent BMI data was collected. We analyzed 60-day all-cause mortality as the primary outcome for the patients. Need for mechanical ventilation and admission to the intensive care unit (ICU) were the secondary outcomes. We also analyzed the treatments for COVID-19, including antibiotics (combining ceftriaxone, azithromycin, piperacillin tazobactam, meropenem, vancomycin, and doxycycline), corticosteroids (combining prednisone, methylprednisolone, dexamethasone, and hydrocortisone), hydroxychloroquine, enoxaparin, heparin, and vasopressor.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-19\u0022\u003E\u003Ch3\u003ESDoH data\u003C\/h3\u003E\u003Cp id=\u0022p-53\u0022\u003ETo explore the impact of SDoH status on the subphenotypes, we extracted patients\u2019 neighborhood socioeconomic characteristics, including median household income, percentage of residents without a high school degree, percentage of residents who are essential workers, percentage of households with crowding housing conditions (i.e., households with \u0026gt;1 person per room), percentage of non-white residents, and unemployment rate. These characteristics were extracted from the 2018 American Community Survey\u003Csup\u003E\u003Ca id=\u0022xref-ref-38-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-38\u0022\u003E38\u003C\/a\u003E\u003C\/sup\u003E. Previous studies have indicated that these social conditions are associated with higher probability of infection, hospitalization, and other adverse outcomes.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-20\u0022\u003E\u003Ch3\u003EStatistical methods\u003C\/h3\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-21\u0022\u003E\u003Ch4\u003EData preparation\u003C\/h4\u003E\u003Cp id=\u0022p-54\u0022\u003EWe first assessed the value distributions and missingness of the 30 candidate clinical variables (see e\u003Ca id=\u0022xref-table-wrap-2-3\u0022 class=\u0022xref-table\u0022 href=\u0022#T2\u0022\u003ETables 2\u003C\/a\u003E and 3 in Supplement). For data quality control, 7 variables of high missingness (missing more than 70% values) were excluded and the remaining 23 variables were used for deriving subphenotypes. Logarithmic transformation was applied to the non-normal distributed variables (see eTable 4 in Supplement). In order to eliminate the effects of value magnitude, all variables were scaled based on z-score. K-nearest neighbors (KNN) imputation\u003Csup\u003E\u003Ca id=\u0022xref-ref-39-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-39\u0022\u003E39\u003C\/a\u003E\u003C\/sup\u003E was used to address missing values (see eMethods in Supplement).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-22\u0022\u003E\u003Ch4\u003ESubphenotype derivation, validation, and prediction\u003C\/h4\u003E\u003Cp id=\u0022p-55\u0022\u003EWe originally derived subphenotypes using the development cohort. More specifically, agglomerative hierarchical clustering with Euclidean distance calculation and Ward linkage criterion\u003Csup\u003E\u003Ca id=\u0022xref-ref-40-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-40\u0022\u003E40\u003C\/a\u003E\u003C\/sup\u003E was applied to the 23 clinical variables after data preparation. We used agglomerative hierarchical clustering because it is robust to different types of data distributions and typically produces a dendrogram that visualizes data structure to help determine the optimal cluster number. Besides dendrogram, we calculated 21 measures of clustering models provided by \u2018NbClust\u2019 software\u003Csup\u003E\u003Ca id=\u0022xref-ref-41-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-41\u0022\u003E41\u003C\/a\u003E\u003C\/sup\u003E to determine the optimal number of clusters, i.e., subphenotypes.\u003C\/p\u003E\u003Cp id=\u0022p-56\u0022\u003EIn order to evaluate the reproducibility, we validated our subphenotypes in three ways. First, we performed sensitivity analyses using the development cohort to evaluate 1) sensitivity to quality control and outliers and 2) sensitivity to clustering algorithms. To assess sensitivity to quality control and outliers, we incorporated all 30 candidate variables and excluded patients who have outlier values (see eMethods in Supplement). Then similar to the primary analysis, we performed agglomerative hierarchical clustering to re-derive subphenotypes and determined optimal cluster number using dendrogram and \u2018NbClust\u2019. To assess sensitivity to clustering algorithms, we re-derived subphenotypes using the Gaussian mixture model (GMM)\u003Csup\u003E\u003Ca id=\u0022xref-ref-42-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-42\u0022\u003E42\u003C\/a\u003E\u003C\/sup\u003E, which is a probabilistic model for clustering analysis based on a mixture of Gaussian distributions. The optimal cluster number in GMM was determined by comprehensively considering Akaike information criterion (AIC), Bayesian information criterion (BIC), and median probability of group membership (see eMethods in Supplement).\u003C\/p\u003E\u003Cp id=\u0022p-57\u0022\u003ESecond, we used the internal validation cohort and re-derived subphenotypes using the same agglomerative hierarchical clustering with the primary analysis for validation. The optimal cluster number was determined using dendrogram and \u2018NbClust\u2019 as well.\u003C\/p\u003E\u003Cp id=\u0022p-58\u0022\u003ELast, for the aims of confirming subphenotypes and their usability, we used the supervised predictive model. More specifically, considering subphenotype membership of each patient as the label to predict, we built a predictive model of subphenotypes based on the 23 clinical variables used for subphenotype derivation. The predictive model was based on the supervised XGBoost classifier\u003Csup\u003E\u003Ca id=\u0022xref-ref-43-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-43\u0022\u003E43\u003C\/a\u003E\u003C\/sup\u003E, a powerful tree-based machine learning model. The predictive model was trained in the development cohort using a 10-fold cross-validation strategy. To address the multi-label classification (since we identified more than 2 subphenotypes), a one-vs-the-rest strategy was used in model training. Prediction performance was measured by receiver operating characteristics curve (ROC) and area under ROC curve (AUC). We also engaged the novel SHapley Additive exPlanation (SHAP) values to assess contributions of the clinical variables in distinguishing each subphenotype from the others. Once the predictive model was trained, it was performed on the external validation cohort to predict the patients\u2019 subphenotype memberships.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-23\u0022\u003E\u003Ch4\u003ESubphenotype interpretation\u003C\/h4\u003E\u003Cp id=\u0022p-59\u0022\u003EFor the aim of subphenotype interpretation, we first visualized the subphenotypes in two ways: 1) 2-D visualization calculated by Uniform Manifold Approximation and Projection (UMAP) algorithm\u003Csup\u003E\u003Ca id=\u0022xref-ref-44-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-44\u0022\u003E44\u003C\/a\u003E\u003C\/sup\u003E based on clinical variables for clustering (showing distributions of subphenotypes within low-dimensional space); 2) chord diagrams\u003Csup\u003E\u003Ca id=\u0022xref-ref-45-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-45\u0022\u003E45\u003C\/a\u003E\u003C\/sup\u003E showing differences of subphenotypes in terms of abnormal clinical variable groups and comorbidities (see eMethods in Supplement).\u003C\/p\u003E\u003Cp id=\u0022p-60\u0022\u003EWe also characterized subphenotypes by evaluating their differences in demographics, all clinical variables, comorbidities, clinical outcomes, and medications prescribed after COVID-19 confirmation. Data were presented as median (interquartile range [IQR]) for continuous variables and exact patient number (percentage) for categorical variables. To compare subphenotypes, we performed the Kruskal-Wallis test for continuous data and X\u003Csup\u003E2\u003C\/sup\u003E test for categorical data. Analysis of covariance (ANCOVA) was also applied for between-subphenotypes comparisons, adjusting for age and gender. Two-tailed P-values smaller than 0.05 were considered as the threshold for statistical significance. Survival analyses were performed to assess associations of subphenotypes to clinical outcomes, where Kaplan-Meier plots were created accordingly.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-24\u0022\u003E\u003Ch4\u003ETemporal pattern of subphenotypes\u003C\/h4\u003E\u003Cp id=\u0022p-61\u0022\u003ETo evaluate the temporal pattern of the subphenotypes during the course of the pandemic, we created bar charts to visualize the proportion of each subphenotype out of the total patients confirmed per week, since the COVID-19 outbreak in NYC (March 1, 2020).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-25\u0022\u003E\u003Ch4\u003EImpacts of SDoH on COVID-19 subphenotypes\u003C\/h4\u003E\u003Cp id=\u0022p-62\u0022\u003EMultiple analyses were conducted to assess the impact of SDoH on COVID-19 subphenotypes. For each subphenotype, we first performed logistic regression analysis to assess the association of each SDoH variable with 60-day mortality, adjusting for age and sex. After that, we performed agglomerative hierarchical clustering on the 6 socioeconomic variables to derive comprehensive SDoH strata. Within each subphenotype, we compared 60-day mortality rates between the SDoH strata. We also used logistic regression analysis to assess the association of SDoH strata with 60-day mortality, adjusting for age and sex, within each subphenotype.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-26\u0022\u003E\u003Ch3\u003EData availability\u003C\/h3\u003E\u003Cp id=\u0022p-63\u0022\u003EAll data studied in this work can be downloaded from INSIGHT clinical research network at \u003Ca href=\u0022https:\/\/insightcrn.org\/our-data\/\u0022\u003Ehttps:\/\/insightcrn.org\/our-data\/\u003C\/a\u003E, via request. Implementation of our work is based on Python 3.7 and R 3.6. More specifically, clustering models were implemented based on Python packages \u2018scikit-learn 0.23.2\u2019 (\u003Ca href=\u0022https:\/\/scikit-learn.org\/stable\/\u0022\u003Ehttps:\/\/scikit-learn.org\/stable\/\u003C\/a\u003E) and \u2018scipy 1.5.3\u2019 (\u003Ca href=\u0022https:\/\/www.scipy.org\u0022\u003Ehttps:\/\/www.scipy.org\u003C\/a\u003E). Supervised predictive modeling was based on \u2018XGBoost 1.2.1\u2019 (\u003Ca href=\u0022https:\/\/xgboost.readthedocs.io\/en\/latest\/\u0022\u003Ehttps:\/\/xgboost.readthedocs.io\/en\/latest\/\u003C\/a\u003E) and \u2018SHAP 0.35.0\u2019 (\u003Ca href=\u0022https:\/\/shap.readthedocs.io\/en\/latest\/\u0022\u003Ehttps:\/\/shap.readthedocs.io\/en\/latest\/\u003C\/a\u003E). Data dimension reduction and visualization were performed based on Python package \u2018UMAP-learn 0.3.9\u2019 (\u003Ca href=\u0022https:\/\/umap-learn.readthedocs.io\/en\/latest\/\u0022\u003Ehttps:\/\/umap-learn.readthedocs.io\/en\/latest\/\u003C\/a\u003E). R package \u2018NbClust\u2019 (\u003Ca href=\u0022https:\/\/cran.r-project.org\/web\/packages\/NbClust\/NbClust.pdf\u0022\u003Ehttps:\/\/cran.r-project.org\/web\/packages\/NbClust\/NbClust.pdf\u003C\/a\u003E) was used to calculate measures of clusters to determine the optimal cluster number in agglomerative hierarchical clustering. Chord diagrams were created using R package \u2018circlize\u2019 (\u003Ca href=\u0022https:\/\/cran.r-project.org\/web\/packages\/circlize\/index.html\u0022\u003Ehttps:\/\/cran.r-project.org\/web\/packages\/circlize\/index.html\u003C\/a\u003E). All statistical tests and survival analyses were performed based on R.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-27\u0022\u003E\u003Ch3\u003EEthical approval and patient consent\u003C\/h3\u003E\u003Cp id=\u0022p-64\u0022\u003EThe Institutional Review Board of the Weill Cornell Medicine approved this study (Protocol number: 20-04021948).\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-28\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAuthor contributions\u003C\/h2\u003E\u003Cp id=\u0022p-66\u0022\u003EES and FW for conceptualization, investigation, writing, reviewing and editing of the manuscript. CS for investigation, data analysis, drafting, editing and reviewing manuscript. MGW for providing data support, discussion and commenting the manuscript. YZ and JHF for discussion, commenting and editing the manuscript.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-29\u0022\u003E\u003Ch2 class=\u0022\u0022\u003ECompeting interests\u003C\/h2\u003E\u003Cp id=\u0022p-67\u0022\u003EThe authors have declared that no conflict of interest exists.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ack\u0022 id=\u0022ack-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAcknowledgements\u003C\/h2\u003E\u003Cp id=\u0022p-65\u0022\u003EThis study is funded by the COVID-19-Related Project Enhancement to the grant PCORI\/HSD-1604-35187 (\u201cIdentifying and Predicting Patients with Preventable High Utilization\u201d, PI: Kaushal) from the Patient-Centered Outcomes Research Institute.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ref-list\u0022 id=\u0022ref-list-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EReferences\u003C\/h2\u003E\u003Col class=\u0022cit-list ref-use-labels\u0022\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E1.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-1-1\u0022 title=\u0022View reference 1. in text\u0022 id=\u0022ref-1\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.1\u0022 data-doi=\u002210.1056\/NEJMoa2001017\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZhu\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EA Novel Coronavirus from Patients with Pneumonia in China, 2019\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EN. Engl. J. Med\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E382\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E727\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E733\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DN.%2BEngl.%2BJ.%2BMed%26rft.volume%253D382%26rft.spage%253D727%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2001017%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1056\/NEJMoa2001017\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F02%2F2021.02.28.21252645.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E2.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-2-1\u0022 title=\u0022View reference 2. in text\u0022 id=\u0022ref-2\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.2\u0022 data-doi=\u002210.1001\/jama.2020.6775\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERichardson\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EPresenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJAMA\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E323\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E2052\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2059\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJAMA%26rft.volume%253D323%26rft.spage%253D2052%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.2020.6775%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1001\/jama.2020.6775\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F02%2F2021.02.28.21252645.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E3.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2021.02.28.21252645v1.3\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETabata\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EClinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EThe Lancet Infectious Diseases\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E20\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1043\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1050\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DThe%2BLancet%2BInfectious%2BDiseases%26rft.volume%253D20%26rft.spage%253D1043%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F02%2F2021.02.28.21252645.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E4.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2021.02.28.21252645v1.4\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDesai\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ETemporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature Communications\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E11\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E6319\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%2BCommunications%26rft.volume%253D11%26rft.spage%253D6319%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E5.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2021.02.28.21252645v1.5\u0022 data-doi=\u002210.1001\/jama.2020.12839.e4\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWiersinga\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EW.J.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERhodes\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECheng\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.C.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPeacock\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.J.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPrescott\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH.C.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EPathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJAMA\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E324\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E782\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E793\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJAMA%26rft.volume%253D324%26rft.spage%253D782%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.2020.12839.e4%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1001\/jama.2020.12839.e4\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F02%2F2021.02.28.21252645.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E6.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2021.02.28.21252645v1.6\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETakahashi\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ESex differences in immune responses that underlie COVID-19 disease outcomes\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E588\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E315\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E320\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D588%26rft.spage%253D315%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E7.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2021.02.28.21252645v1.7\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGupta\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EAssociation Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJAMA Internal Medicine\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E181\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E41\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E51\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJAMA%2BInternal%2BMedicine%26rft.volume%253D181%26rft.spage%253D41%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E8.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-8-1\u0022 title=\u0022View reference 8. in text\u0022 id=\u0022ref-8\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.8\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDomecq\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.P.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EOutcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECrit. Care Med\u003C\/abbr\u003E. Online First(9000).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E9.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-9-1\u0022 title=\u0022View reference 9. in text\u0022 id=\u0022ref-9\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.9\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-article-title\u0022\u003EDexamethasone in Hospitalized Patients with Covid-19 \u2014 Preliminary Report\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EN. Engl. J. Med\u003C\/abbr\u003E. (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E10.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-10-1\u0022 title=\u0022View reference 10. in text\u0022 id=\u0022ref-10\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2021.02.28.21252645v1.10\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKreuziger\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL.B.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-source\u0022\u003ECOVID-19 and VTE\/Anticoagulation: Frequently Asked Questions\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E (\u003Cspan class=\u0022cit-publ-name\u0022\u003EThe American Society of Hematology\u003C\/span\u003E, accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003Eby Feb 8, 2021\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E11.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-11-1\u0022 title=\u0022View reference 11. in text\u0022 id=\u0022ref-11\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2021.02.28.21252645v1.11\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-source\u0022\u003EFull-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E (\u003Cspan class=\u0022cit-publ-name\u0022\u003ENational Institutes of Health (NIH)\u003C\/span\u003E, accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003Eby Feb 10, 2021\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E12.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-12-1\u0022 title=\u0022View reference 12. in text\u0022 id=\u0022ref-12\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.12\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWeng\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EShah\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN.H.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHripcsak\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EDeep phenotyping: Embracing complexity and temporality-Towards scalability, portability, and interoperability\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ. Biomed. Inform\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E105\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E103433\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ.%2BBiomed.%2BInform%26rft.volume%253D105%26rft.spage%253D103433%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E13.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-13-1\u0022 title=\u0022View reference 13. in text\u0022 id=\u0022ref-13\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.13\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EReddy\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ESubphenotypes in critical care: translation into clinical practice\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EThe Lancet Respiratory Medicine\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E8\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E631\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E643\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DThe%2BLancet%2BRespiratory%2BMedicine%26rft.volume%253D8%26rft.spage%253D631%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E14.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-14-1\u0022 title=\u0022View reference 14. in text\u0022 id=\u0022ref-14\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.14\u0022 data-doi=\u002210.1001\/jama.2019.5791\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESeymour\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC.W.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EDerivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJAMA\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E321\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E2003\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2017\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2019\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJAMA%26rft.volume%253D321%26rft.spage%253D2003%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.2019.5791%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1001\/jama.2019.5791\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F02%2F2021.02.28.21252645.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E15.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-15-1\u0022 title=\u0022View reference 15. in text\u0022 id=\u0022ref-15\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.15\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBhavani\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.V.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EIdentifying Novel Sepsis Subphenotypes Using Temperature Trajectories\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAm. J. Respir. Crit. Care Med\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E200\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E327\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E335\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2019\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DAm.%2BJ.%2BRespir.%2BCrit.%2BCare%2BMed%26rft.volume%253D200%26rft.spage%253D327%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E16.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-16-1\u0022 title=\u0022View reference 16. in text\u0022 id=\u0022ref-16\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.16\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECalfee\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC.S.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ESubphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EThe Lancet Respiratory Medicine\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E2\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E611\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E620\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DThe%2BLancet%2BRespiratory%2BMedicine%26rft.volume%253D2%26rft.spage%253D611%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E17.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-17-1\u0022 title=\u0022View reference 17. in text\u0022 id=\u0022ref-17\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.17\u0022 data-doi=\u002210.1016\/j.jacc.2014.07.979\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAhmad\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EClinical Implications of Chronic Heart Failure Phenotypes Defined by Cluster Analysis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ. Am. Coll. Cardiol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E64\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1765\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1774\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bthe%2BAmerican%2BCollege%2Bof%2BCardiology%26rft.stitle%253DJACC%26rft.aulast%253DAhmad%26rft.auinit1%253DT.%26rft.volume%253D64%26rft.issue%253D17%26rft.spage%253D1765%26rft.epage%253D1774%26rft.atitle%253DClinical%2BImplications%2Bof%2BChronic%2BHeart%2BFailure%2BPhenotypes%2BDefined%2Bby%2BCluster%2BAnalysis%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jacc.2014.07.979%26rft_id%253Dinfo%253Apmid%252F25443696%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6MzoiUERGIjtzOjExOiJqb3VybmFsQ29kZSI7czo0OiJhY2NqIjtzOjU6InJlc2lkIjtzOjEwOiI2NC8xNy8xNzY1IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDMvMDIvMjAyMS4wMi4yOC4yMTI1MjY0NS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E18.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-18-1\u0022 title=\u0022View reference 18. in text\u0022 id=\u0022ref-18\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.18\u0022 data-doi=\u002210.1002\/ejhf.1333\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECikes\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EMachine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EEur. J. Heart Fail\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E21\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E74\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E85\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2019\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DEur.%2BJ.%2BHeart%2BFail%26rft.volume%253D21%26rft.spage%253D74%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fejhf.1333%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1002\/ejhf.1333\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E19.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-19-1\u0022 title=\u0022View reference 19. in text\u0022 id=\u0022ref-19\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.19\u0022 data-doi=\u002210.1126\/scitranslmed.aaa9364\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELi\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EIdentification of type 2 diabetes subgroups through topological analysis of patient similarity\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ESci. Transl. Med\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E7\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E311ra174\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2015\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DScience%2BTranslational%2BMedicine%26rft.stitle%253DSci%2BTransl%2BMed%26rft.aulast%253DLi%26rft.auinit1%253DL.%26rft.volume%253D7%26rft.issue%253D311%26rft.spage%253D311ra174%26rft.epage%253D311ra174%26rft.atitle%253DIdentification%2Bof%2Btype%2B2%2Bdiabetes%2Bsubgroups%2Bthrough%2Btopological%2Banalysis%2Bof%2Bpatient%2Bsimilarity%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscitranslmed.aaa9364%26rft_id%253Dinfo%253Apmid%252F26511511%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6InNjaXRyYW5zbWVkIjtzOjU6InJlc2lkIjtzOjE0OiI3LzMxMS8zMTFyYTE3NCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIxLzAzLzAyLzIwMjEuMDIuMjguMjEyNTI2NDUuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E20.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-20-1\u0022 title=\u0022View reference 20. in text\u0022 id=\u0022ref-20\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.20\u0022 data-doi=\u002210.1126\/sciadv.abb5398\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ENeff\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER.A.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EMolecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EScience Advances\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E7\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003Eeabb5398\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DScience%2BAdvances%26rft.stitle%253DSci%2BAdv%26rft.aulast%253DNeff%26rft.auinit1%253DR.%2BA.%26rft.volume%253D7%26rft.issue%253D2%26rft.spage%253Deabb5398%26rft.epage%253Deabb5398%26rft.atitle%253DMolecular%2Bsubtyping%2Bof%2BAlzheimers%2Bdisease%2Busing%2BRNA%2Bsequencing%2Bdata%2Breveals%2Bnovel%2Bmechanisms%2Band%2Btargets%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fsciadv.abb5398%26rft_id%253Dinfo%253Apmid%252F33523961%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6MzoiUERGIjtzOjExOiJqb3VybmFsQ29kZSI7czo4OiJhZHZhbmNlcyI7czo1OiJyZXNpZCI7czoxMjoiNy8yL2VhYmI1Mzk4IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDMvMDIvMjAyMS4wMi4yOC4yMTI1MjY0NS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E21.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-21-1\u0022 title=\u0022View reference 21. in text\u0022 id=\u0022ref-21\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.21\u0022 data-doi=\u002210.1183\/13993003.01768-2020\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBos\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL.D.J.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESinha\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDickson\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER.P.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EThe perils of premature phenotyping in COVID-19: a call for caution\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EEur. Respir. J\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E56\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E2001768\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DEur.%2BRespir.%2BJ%26rft_id%253Dinfo%253Adoi%252F10.1183%252F13993003.01768-2020%26rft_id%253Dinfo%253Apmid%252F32482788%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiZXJqIjtzOjU6InJlc2lkIjtzOjEyOiI1Ni8xLzIwMDE3NjgiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMS8wMy8wMi8yMDIxLjAyLjI4LjIxMjUyNjQ1LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E22.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-22-1\u0022 title=\u0022View reference 22. in text\u0022 id=\u0022ref-22\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.22\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBhavani\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.V.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHuang\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE.S.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EVerhoef\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP.A.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EChurpek\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.M.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ENovel Temperature Trajectory Subphenotypes in COVID-19\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EChest\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E158\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E2436\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2439\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DChest%26rft.volume%253D158%26rft.spage%253D2436%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E23.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-23-1\u0022 title=\u0022View reference 23. in text\u0022 id=\u0022ref-23\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.23\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELegrand\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EDifferences in clinical deterioration among three sub-phenotypes of COVID-19 patients at the time of first positive test: results from a clustering analysis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EIntensive Care Med\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E47\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E113\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E115\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIntensive%2BCare%2BMed%26rft.volume%253D47%26rft.spage%253D113%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E24.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-24-1\u0022 title=\u0022View reference 24. in text\u0022 id=\u0022ref-24\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.24\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESu\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EIdentifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EmedRxiv\u003C\/abbr\u003E, 2020.2007.2016.20155382 (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E25.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-25-1\u0022 title=\u0022View reference 25. in text\u0022 id=\u0022ref-25\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.25\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAsch\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.A.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EVariation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJAMA Internal Medicine\u003C\/abbr\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E26.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-26-1\u0022 title=\u0022View reference 26. in text\u0022 id=\u0022ref-26\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.26\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EJorge\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ETemporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EThe Lancet Rheumatology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E3\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003Ee131\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003Ee137\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DThe%2BLancet%2BRheumatology%26rft.volume%253D3%26rft.spage%253D131e%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E27.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-27-1\u0022 title=\u0022View reference 27. in text\u0022 id=\u0022ref-27\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.27\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGray\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.M.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAnyane-Yeboa\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBalzora\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EIssaka\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER.B.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMay\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF.P.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ECOVID-19 and the other pandemic: populations made vulnerable by systemic inequity\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature Reviews Gastroenterology \u0026amp; Hepatology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E17\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E520\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E522\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%2BReviews%2BGastroenterology%2B%2526%2BHepatology%26rft.volume%253D17%26rft.spage%253D520%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E28.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-28-1\u0022 title=\u0022View reference 28. in text\u0022 id=\u0022ref-28\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.28\u0022 data-doi=\u002210.1001\/jama.2020.7197\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWadhera\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER.K.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EVariation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJAMA\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E323\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E2192\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2195\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJAMA%26rft.volume%253D323%26rft.spage%253D2192%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.2020.7197%26rft_id%253Dinfo%253Apmid%252F32347898%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1001\/jama.2020.7197\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=32347898\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F02%2F2021.02.28.21252645.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E29.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-29-1\u0022 title=\u0022View reference 29. in text\u0022 id=\u0022ref-29\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.29\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAzar\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK.M.J.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EDisparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHealth Aff. (Millwood)\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E39\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1253\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1262\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DHealth%2BAff.%2B%2528Millwood%2529%26rft.volume%253D39%26rft.spage%253D1253%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E30.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-30-1\u0022 title=\u0022View reference 30. in text\u0022 id=\u0022ref-30\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.30\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBravata\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.M.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EAssociation of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJAMA Network Open\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E4\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003Ee2034266\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003Ee2034266\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJAMA%2BNetwork%2BOpen%26rft.volume%253D4%26rft.spage%253D2034266e%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E31.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-31-1\u0022 title=\u0022View reference 31. in text\u0022 id=\u0022ref-31\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.31\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKnox\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.B.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELanspa\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.J.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKuttler\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK.G.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBrewer\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.C.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBrown\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.M.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EPhenotypic clusters within sepsis-associated multiple organ dysfunction syndrome\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EIntensive Care Med\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E41\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E814\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E822\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2015\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIntensive%2BCare%2BMed%26rft.volume%253D41%26rft.spage%253D814%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E32.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-32-1\u0022 title=\u0022View reference 32. in text\u0022 id=\u0022ref-32\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.32\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EThompson\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC.N.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ECOVID-19 Outbreak - New York City, February 29-June 1, 2020\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMorbidity and mortality weekly report (MMWR)\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E69\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1725\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1729\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DMorbidity%2Band%2Bmortality%2Bweekly%2Breport%2B%2528MMWR%2529%26rft.volume%253D69%26rft.spage%253D1725%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E33.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-33-1\u0022 title=\u0022View reference 33. in text\u0022 id=\u0022ref-33\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.33\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EZ.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EAnalysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EmedRxiv\u003C\/abbr\u003E, 2020.2004.2028.20075788 (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E34.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-34-1\u0022 title=\u0022View reference 34. in text\u0022 id=\u0022ref-34\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.34\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EFedergruen\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ENaha\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EVariation in Covid-19 Cases Across New York City\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EmedRxiv\u003C\/abbr\u003E, 2020.2005.2025.20112797 (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E35.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-35-1\u0022 title=\u0022View reference 35. in text\u0022 id=\u0022ref-35\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.35\u0022 data-doi=\u002210.1136\/bmj.m1328\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWynants\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EPrediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBMJ\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E369\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003Em1328\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.m1328%26rft_id%253Dinfo%253Apmid%252F32265220%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjE3OiIzNjkvYXByMDdfMi9tMTMyOCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIxLzAzLzAyLzIwMjEuMDIuMjguMjEyNTI2NDUuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E36.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-36-1\u0022 title=\u0022View reference 36. in text\u0022 id=\u0022ref-36\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.36\u0022 data-doi=\u002210.1136\/amiajnl-2014-002764\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKaushal\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EChanging the research landscape: the New York City Clinical Data Research Network\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ. Am. Med. Inform. Assoc\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E21\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E587\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E590\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ.%2BAm.%2BMed.%2BInform.%2BAssoc%26rft_id%253Dinfo%253Adoi%252F10.1136%252Famiajnl-2014-002764%26rft_id%253Dinfo%253Apmid%252F24821739%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1136\/amiajnl-2014-002764\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=24821739\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F02%2F2021.02.28.21252645.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E37.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-37-1\u0022 title=\u0022View reference 37. in text\u0022 id=\u0022ref-37\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.37\u0022 data-doi=\u002210.1093\/bioinformatics\/17.6.520\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETroyanskaya\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EO.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EMissing value estimation methods for DNA microarrays\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBioinformatics\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E17\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E520\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E525\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2001\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBioinformatics%26rft.stitle%253DBioinformatics%26rft.aulast%253DTroyanskaya%26rft.auinit1%253DO.%26rft.volume%253D17%26rft.issue%253D6%26rft.spage%253D520%26rft.epage%253D525%26rft.atitle%253DMissing%2Bvalue%2Bestimation%2Bmethods%2Bfor%2BDNA%2Bmicroarrays%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fbioinformatics%252F17.6.520%26rft_id%253Dinfo%253Apmid%252F11395428%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1093\/bioinformatics\/17.6.520\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=11395428\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F02%2F2021.02.28.21252645.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000169404700005\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003C\/ol\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ref-list\u0022 id=\u0022ref-list-2\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EReferences\u003C\/h2\u003E\u003Col class=\u0022cit-list ref-use-labels\u0022\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E38.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-38-1\u0022 title=\u0022View reference 38. in text\u0022 id=\u0022ref-38\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.38\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAmerican Community Survey: 2018 Data Release New and Notable\u003C\/abbr\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E39.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-39-1\u0022 title=\u0022View reference 39. in text\u0022 id=\u0022ref-39\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.39\u0022 data-doi=\u002210.1093\/bioinformatics\/17.6.520\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETroyanskaya\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EO.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EMissing value estimation methods for DNA microarrays\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBioinformatics\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E17\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E520\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E525\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2001\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBioinformatics%26rft.stitle%253DBioinformatics%26rft.aulast%253DTroyanskaya%26rft.auinit1%253DO.%26rft.volume%253D17%26rft.issue%253D6%26rft.spage%253D520%26rft.epage%253D525%26rft.atitle%253DMissing%2Bvalue%2Bestimation%2Bmethods%2Bfor%2BDNA%2Bmicroarrays%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fbioinformatics%252F17.6.520%26rft_id%253Dinfo%253Apmid%252F11395428%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1093\/bioinformatics\/17.6.520\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=11395428\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F02%2F2021.02.28.21252645.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000169404700005\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E40.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-40-1\u0022 title=\u0022View reference 40. in text\u0022 id=\u0022ref-40\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.40\u0022 data-doi=\u002210.1007\/s00357-014-9161-z\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMurtagh\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELegendre\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EWard\u2019s Hierarchical Agglomerative Clustering Method: Which Algorithms Implement Ward\u2019s Criterion?\u003C\/span\u003E \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJournal of Classification\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E31\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E274\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E295\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJournal%2Bof%2BClassification%26rft.volume%253D31%26rft.spage%253D274%26rft_id%253Dinfo%253Adoi%252F10.1007%252Fs00357-014-9161-z%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1007\/s00357-014-9161-z\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E41.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-41-1\u0022 title=\u0022View reference 41. in text\u0022 id=\u0022ref-41\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.41\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECharrad\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGhazzali\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBoiteau\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EV.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ENiknafs\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ENbClust: An R Package for Determining the Relevant Number of Clusters in a Data Set\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJournal of Statistical Software\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E61\u003C\/span\u003E(\u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E42.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-42-1\u0022 title=\u0022View reference 42. in text\u0022 id=\u0022ref-42\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.42\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EReynolds\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.A.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EGaussian Mixture Models\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EEncyclopedia of biometrics\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E741\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E659\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E663\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2009\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DEncyclopedia%2Bof%2Bbiometrics%26rft.volume%253D741%26rft.spage%253D659%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E43.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-43-1\u0022 title=\u0022View reference 43. in text\u0022 id=\u0022ref-43\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2021.02.28.21252645v1.43\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EChen\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGuestrin\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-chapter-title\u0022\u003EXGBoost: A Scalable Tree Boosting System\u003C\/span\u003E. in \u003Cspan class=\u0022cit-source\u0022\u003EProceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining\u003C\/span\u003E \u003Cspan class=\u0022cit-fpage\u0022\u003E785\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E794\u003C\/span\u003E (\u003Cspan class=\u0022cit-publ-name\u0022\u003EAssociation for Computing Machinery\u003C\/span\u003E, \u003Cspan class=\u0022cit-publ-loc\u0022\u003ESan Francisco, California, USA\u003C\/span\u003E, \u003Cspan class=\u0022cit-pub-date\u0022\u003E2016\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E44.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-44-1\u0022 title=\u0022View reference 44. in text\u0022 id=\u0022ref-44\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.44\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMcInnes\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHealy\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMelville\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EUmap: Uniform manifold approximation and projection for dimension reduction\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EarXiv preprint\u003C\/abbr\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-arxiv-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003EarXiv:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-arxiv\u0022\u003E1802.03426\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2018\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E45.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-45-1\u0022 title=\u0022View reference 45. in text\u0022 id=\u0022ref-45\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2021.02.28.21252645v1.45\u0022 data-doi=\u002210.1093\/bioinformatics\/btu393\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGu\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EZ.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGu\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EEils\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESchlesner\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E\u003C\/span\u003E \u0026amp; \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBrors\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003Ecirclize implements and enhances circular visualization in R\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBioinformatics\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E30\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E2811\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2812\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBioinformatics%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fbioinformatics%252Fbtu393%26rft_id%253Dinfo%253Apmid%252F24930139%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1093\/bioinformatics\/btu393\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=24930139\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F02%2F2021.02.28.21252645.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000343082900017\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003C\/ol\u003E\u003C\/div\u003E\u003Cspan class=\u0022highwire-journal-article-marker-end\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Cspan class=\u0022related-urls\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_zP7WWIfzbyzvaM63L39cNV2juU_1XVH7wduFK9gcMNI.js\u0022\u003E\u003C\/script\u003E\n\u003C\/body\u003E\u003C\/html\u003E"}